trending Market Intelligence /marketintelligence/en/news-insights/trending/3rr0idckbo4kknr0wdly5g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

OptimizeRx names board members

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

OptimizeRx names board members

OptimizeRx Corp. appointed Patrick Spangler and Bryan Archambault to its board.

Spangler succeeds Jack Pinney, who was appointed the head of the company's medical advisory board. Spangler is the CFO of VigiLanz, a digital healthcare intelligence firm, and is a board member of Lifespace Communities.

Archambault replaces Lynn O'Connor Vos as representative of WPP, a strategic investor in OptimizeRx. Archambault serves as the chief marketing officer of WPP unit greyhealth group, or ghg, Kansas City.

Vos left her position as CEO of greyhealth group to become CEO of the Muscular Dystrophy Association. She will remain on OptimizeRx's board as an independent director.

Rochester, Mich.-based OptimizeRx provides digital health messaging services, providing a direct channel for pharmaceutical companies to communicate with healthcare providers.